Journal profile · Clinical Neurology
Alzheimers & Dementia
ISSN 1552-5260 · eISSN 1552-5279 · Elsevier Inc. · UNITED STATES · Quarterly · Founded 2005
Alzheimers & Dementia: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 11.47; hybrid open access; APC about USD 4,200; median 105 days to acceptance (97 articles, last 24 months); community-reported acceptance: hard; 7,202 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Alzheimers & Dementia is published by Elsevier Inc. and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Functional Brain Connectivity Studies, together about 56.8% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
<em>Alzheimer's & Dementia</em>® journal aims to bridge the knowledge gaps across a wide range of bench-to-bedside investigation in dementia and Alzheimer's Disease.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Editor-in-chief Donna M. WilcockPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dementia and Cognitive Impairment ResearchMedicine30.4%
- Alzheimer's disease research and treatmentsMedicine21.4%
- Functional Brain Connectivity StudiesNeuroscience5.1%
- Neurological Disease Mechanisms and TreatmentsNeuroscience4.5%
- Cholinesterase and Neurodegenerative DiseasesMedicine4.2%
- Advanced Neuroimaging Techniques and ApplicationsMedicine3.7%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience3.3%
- Health, Environment, Cognitive AgingEnvironmental Science3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Clinical Neurology | Zone 1 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 11.47LetPub ·
- Impact factor (publisher) 2025
- 12.8Publisher website ·
- CiteScore 2026-06
- 13.9LetPub ·
- CiteScore (publisher) 2025
- 13.9Publisher website ·
- SJR 2026-06
- 4.53LetPub ·
- SNIP 2026-06
- 2.86LetPub ·
- h-index
- 94LetPub ·
- h-index
- 232OpenAlex ·
- i10-index
- 3,496OpenAlex ·
- 2-year mean citedness
- 2.18OpenAlex ·
- Self-citation rate
- 11.7%LetPub ·
- Share of gold OA articles
- 90.78%LetPub ·
Volume
- Articles per year
- 1,057LetPub ·
- Articles per year (publisher) 2025
- 1,121Publisher website ·
- Downloads per year (publisher) 2025
- 6,867,377Publisher website ·
Articles by year OpenAlex count · 66,237 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 840 | 830 | 637 |
| 2025 | 7,202 | 7,181 | 9,723 |
| 2024 | 6,089 | 6,067 | 20,495 |
| 2023 | 7,086 | 6,466 | 20,559 |
| 2022 | 2,952 | 732 | 19,988 |
| 2021 | 3,019 | 1,061 | 22,197 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
105 daysMedian, submission to acceptance · P25–P75 84 days – 141 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 97 articles with submission and acceptance dates (2,231 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- HardLetPub ·
- Acceptance rate (publisher) 2025
- 33%Publisher website ·
- Submission to first decision 2025
- 8 daysPublisher website ·
- Submission to acceptance 2025
- 98 daysPublisher website ·
- Acceptance to publication 2025
- 40 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,200 / EUR 3,570 / GBP 3,200 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 2005
- ISSN
- 1552-5260
- Electronic ISSN
- 1552-5279
- Latest issue on the website
- Volume 22, Issue 9 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Alzheimers & Dementia
What CAS zone is Alzheimers & Dementia in?
In the 2025 upgraded edition of the CAS Journal Ranking, Alzheimers & Dementia is in Zone 1 of Medicine, and in Zone 1 of the minor category Clinical Neurology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Alzheimers & Dementia?
The latest impact factor listed by LetPub is 11.47; CiteScore 13.9, h-index 232.
How long does peer review take at Alzheimers & Dementia?
Based on the dates recorded on 97 articles published between September 2024 and September 2026 (the last 24 months), the median time from submission to acceptance is 105 days (interquartile range 84–141 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Hard”; the journal's website gives an acceptance rate of 33% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Alzheimers & Dementia?
According to LetPub and DOAJ records, Alzheimers & Dementia is indexed in SCIE and Scopus.
Is Alzheimers & Dementia open access, and what is the APC?
Alzheimers & Dementia is a hybrid journal. For open-access publication: APC about USD 4,200.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .